Amrita Y. Krishnan, MD
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amrita Y. Krishnan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:29 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02500849 · Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsCity of Hope Medical Center · active not recruiting · HIV · principal investigator
- Ph3NCT02366663 · BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCLCity of Hope Medical Center · terminated · Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma
- Ph2NCT00695409 · Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin LymphomaCity of Hope Medical Center · completed · Lymphoma · principal investigator
- Ph1NCT00641381 · Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaCity of Hope Medical Center · completed · Lymphoma · principal investigator
- Ph1NCT00569985 · Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related LymphomaCity of Hope Medical Center · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Hematopoietic Cell Transplantation for Hematologic MalignanciesP01CA030206 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Stephen J Forman · fiscal years 2008 to 2010Named on NCT00695409
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2008 to 2026Named on NCT00695409, NCT00641381
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.